Table 4.
Inactivation of enveloped viruses in the Gamunex® process intermediate containing 20 mm caprylate during incubation at 24 °C: within 10 min, all viruses were undetectable
| Virus | Models | |
|---|---|---|
| Log10 reduction | ||
| HIV a | HIV‐1, HIV‐2 | 4·5 |
| PRV a | Human herpes viruses, HBV | 4·6 |
| BVDV a | HCV | 4·5 |
| Sindbis b | HCV | 6·0 |
| DHBV | HBV | 4·6 |
| WNV c | Relevant | 5·0 |
| VV d | Relevant, variola, monkeypox | 6·0 |
Data obtained from a previously published reference [18].
From Table 5.
From Fig. 3(a).
From Fig. 3(b).
BVDV, bovine viral diarrhoea virus; DHBV, duck hepatitis B virus; HBV, hepatitis B virus; HCV, hepatitis C virus; HIV, human immunodeficiency virus; PRV, pseudorabies virus; WNV, West Nile virus; VV, vaccinia virus.
The reduction factor for VV represents a single determination. All other reduction factors were the mean of three determinations.